Last edition
News about "Anurag Kumar"
Biodeal Acquires Biological E Facility for Sterile Injectables
Biodeal Pharmaceuticals acquires a Biological E facility, adding 135 million-unit annual capacity, with its Carbapenem line now operational and validated.
Anurag Kumar | 30/09/2026 | By News Bureau | 111
Biodeal Pharmaceuticals Concludes Piramal Alternatives Partnership
Biodeal delivered strong revenue growth during the hold period, with EBITDA margins improving alongside continued investment in manufacturing and governance.
Anurag Kumar | 28/07/2026 | By News Bureau | 137
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy